Cargando…
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment
BACKGROUND: Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in inhabitants from low-income countries and in visitors to these countries. The impact of the human intestinal microbiota on the initiation and progression of ETEC diarrhea is not yet well understood. RESULTS: We used...
Autores principales: | Pop, Mihai, Paulson, Joseph N., Chakraborty, Subhra, Astrovskaya, Irina, Lindsay, Brianna R., Li, Shan, Bravo, Héctor Corrada, Harro, Clayton, Parkhill, Julian, Walker, Alan W., Walker, Richard I., Sack, David A., Stine, O. Colin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898365/ https://www.ncbi.nlm.nih.gov/pubmed/27277524 http://dx.doi.org/10.1186/s12864-016-2777-0 |
Ejemplares similares
-
Development of a novel multiplex electrochemiluminescent-based immunoassay to aid enterotoxigenic Escherichia coli vaccine development and evaluations
por: Chakraborty, Subhra, et al.
Publicado: (2019) -
Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers
por: Chakraborty, Subhra, et al.
Publicado: (2018) -
Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model
por: Brubaker, Jessica, et al.
Publicado: (2021) -
Robust methods for differential abundance analysis in marker gene surveys
por: Paulson, Joseph N., et al.
Publicado: (2013) -
Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)